$8.430
+0.020 (+0.24%)At close
JYNT News
JYNT Events
The Joint Corp. Reports Q2 Revenue of $15.18M
Reports Q2 revenue $15.18M, consensus $14.57M. "In the second quarter, we continued to see the benefits of our Joint 2.0 strategy take hold, with our actions to optimize the clinic portfolio, streamline our operating structure, and elevate the patient experience driving improved operating efficiency and strong free cash flow," said President and Chief Executive Officer of The Joint Corp., Sanjiv Razdan. "We are encouraged with another quarter of revenue growth, as well as the improvement in comp trends compared to the first quarter. We are also seeing the early benefits of our flexible membership options, which contributed to strengthening patient retention. In addition, our national marketing initiative is leveraging consumer research to uncover emerging patient trends, ensuring our offerings align with what patients are seeking from chiropractic care."
Company Expects System-wide Sales Between $519 Million and $552 Million
The company said, "System-wide sales are expected to be between $519 million and $552 million. System-wide comp sales for clinics open 13 months or more are expected to be in the range of (3)% to 3%."
Company Expects 30 to 35 New Franchise Clinics Openings
The company said, "New franchised clinic openings, excluding the impact of refranchised clinics, are expected to be in the range of 30 to 35. The Company is working with franchise owners to optimize the performance of the existing franchised clinic base. This may include closing underperforming clinics this year, which will result in the overall clinic count at 2026 year end being lower than 2025 year end."
The Joint Corp. Q1 Revenue $14.82M, Exceeds Expectations
Reports Q1 revenue $14.82M, consensus $14.5M. "During the first quarter of 2026, we continued to build a more efficient and profitable platform, advancing our refranchising efforts, optimizing our clinic portfolio, and tightening our operating structure across the system," said President and Chief Executive Officer of The Joint Corp., Sanjiv Razdan. "In April, we entered into an agreement for the sale of 45 of our company-owned or managed clinics, effectively completing our Joint 2.0 refranchising initiative, with fewer than 1% of our remaining clinic portfolio being company-owned or managed. At the same time, we remain active with our capital allocation priorities with continued share repurchases, as well as the recent completion of three regional developer buybacks that further optimize our portfolio economics."
Joint Corp. Sells 45 Clinics to Elite Chiro Group for $2.3M
Joint Corp. announced that it has signed an asset purchase agreement effective on April 20 for the sale of 45 corporate managed clinics in Southern California to Elite Chiro Group for approximately $2.3M. Pursuant to the APA, Elite Chiro Group will assume business operations of 32 of those clinics April 27 through a management service agreement until lease assignments are completed to permit the clinics' ownership transfer, and will assume ownership of the remaining 13 corporate-managed clinics. Upon completion, this transaction, together with two previously announced refranchising agreements pending closing, will reduce the company's corporate managed clinics to just three out of 960 locations in its total clinic portfolio.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。